Stay updated on Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The Nivolumab with standard-of-care chemotherapy study record is now displayed, including its completed status, study design, participant criteria, locations, and outcome measures.
    Difference
    67%
    Check dated 2026-11-08T15:12:41.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.2 to v3.8.0.
    Difference
    0.3%
    Check dated 2026-11-01T16:21:42.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434. The clinical trial record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-25T18:59:36.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:37:08.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T22:41:03.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, blocking access to the study record. The content is replaced with minimal navigation and site chrome indicating restricted access.
    Difference
    21%
    Check dated 2026-09-20T22:22:41.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page.